期刊文献+

口腔黏膜给药系统的药物动力学研究进展 被引量:10

Progress in pharmacokinetics of oral transmucosal drug delivery systems
原文传递
导出
摘要 口腔黏膜给药(oral transmucosal drug delivery)指药物经过口腔黏膜吸收进入体循环而发挥药效,具有生物利用度高、起效快等优势。本文介绍了口腔黏膜的生理特点,详细分析了影响口腔黏膜给药系统药物动力学性质的因素,如口腔生理屏障、不同给药部位、药物理化性质、剂型因素和处方因素,阐述了体外渗透性、在体口腔吸收、体内药物动力学以及生理药代动力学模型等研究在口腔黏膜给药系统药物动力学研究中的应用,为口腔黏膜给药系统开发提供方法和借鉴。 Oral transmucosal drug delivery can be defined as the administration of drug through the oral mucosa to achieve systemic effects.It has the advantages of high bioavailability and rapid drug response.In this review,we introduce the physiology of oral mucosa,and analyze the factors affecting the pharmacokinetic properties of oral transmucosal drug delivery in detail,such as physiological barriers,different administration sites,physicochemical properties of drugs,dosage forms,and formulation strategies.In addition,we describe the methods to evaluate the pharmacokinetic properties of this delivery systems,including in vitro permeability studies,buccal absorption studies,in vivo pharmacokinetic studies and physiologically based pharmacokinetics(PBPK)modeling,which provide methods and reference for the development of oral transmucosal drug delivery systems.
作者 王冰 刘宏锐 陈芳 全应军 相小强 WANG Bing;LIU Hong-rui;CHEN Fang;QUAN Ying-jun;XIANG Xiao-qiang(National Pharmaceutical Engineering Research Center,China State Institute of Pharmaceutical Industry,Shanghai 201203,China;Fudan University Pudong Medical Center,Shanghai 201300,China;School of Pharmacy,Fudan University,Shanghai 201203,China)
出处 《药学学报》 CAS CSCD 北大核心 2020年第2期226-234,共9页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81473409) 上海市科委研发平台建设专项(18DZ2290500) 复旦大学附属浦东医院-复旦大学药学院战略合作融合基金(RHJJ2017-05)
关键词 口腔黏膜吸收 药物传递系统 药物动力学 渗透性 剂型 oral mucosal absorption drug delivery system pharmacokinetics permeability dosage form
  • 相关文献

参考文献6

二级参考文献50

  • 1田卫群,罗勇,高秋华,黄开勋,徐辉碧.磷酸盐缓冲介质促进胰岛素透口腔黏膜渗透作用机制研究[J].中国药理学通报,2003,19(12):1354-1358. 被引量:3
  • 2CAMPISI G,PADERNI C,SACCONE R,et al.Human buccal mucosa as an innovative site of drug delivery[J].Curr Pharm Des,2010,16(6):641-652.
  • 3SUFHAKAR Y,KUOTSU K,BANDYOPADHYAY AK.Buccal bioadhesive drug delivery-A promising option for orally less effi-cient drug[J].J Control Release,2006,114(1):15-40.
  • 4KULKARNI U,MAHALINGAM R,PATHER SI,et al.Porcine buccal mucosa as an in vitro model:relative contribution of epi-thelium and connective tissue as permeability barriers[J].J Pharm Sci,2009,98(2):471-483.
  • 5LIU C,XU HN,LI XL.In vitro permeation of tetramethylpyrazine across porcine buccal mucosa[J].Acta Pharmacol Sin,2002,23(9):792-796.
  • 6NICOLAZZO JA,REED BL,FINNIN BC.Buccal penetration enhancers-How do they really work?[J].J Control Release,2005,105(1-2):1-15.
  • 7KOKATE A,LI X,JASTI B.Effect of Drug lipophilicity and i-onization on permeability across the buccal mucosa:a technical note[J].AAPS PharmSciTech,2008,9(2):501-504.
  • 8KOKATE A,LI X,WILLIAMS PJ,et al.In silico prediction ofdrug permeability across buccal mucosa[J].Pharm Res,2009,26(5):1130-1139.
  • 9DE CARO V,GIANDALIA G,SIRAQUSA MG,et al.Evalua-tion of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models:part I[J].Eur J Pharm Biopharm,2008,70(3):869-873.
  • 10NICOLAZZO JA,REED BL,FINNIN BC.Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide[J].J Control Release,2005,105(3):240-248.

共引文献36

同被引文献85

引证文献10

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部